eIF4A emerges as a potential Achilles’ heel for triple-negative breast cancer
Targeting eIF4A to interfere with the synthesis of proteins the cancer needs to grow is producing promising results.
Read More
Zotatifin
Targeting eIF4A to interfere with the synthesis of proteins the cancer needs to grow is producing promising results.
Read More